Document is current
Any future updates will be listed below
-
Authors
Feighan, Kira M.
Nesan, Dinushan
Kurrasch, Deborah M.
- License Information
-
More Information
Article History
Received: 29 September 2023
Accepted: 3 July 2024
First Online: 12 July 2024
Competing interests
: D.M.K. is the co-founder of Path Therapeutics, focused on the development of drugs for rare pediatric epilepsies. The other authors declare no conflicts.
